AGE AGE

AgeX Therapeutics Stock Price

0.571408
-0.02889 (-4.81%)
Upgrade to Real-Time
Regular Market
0.571408
Volume 23,817
Bid Price
Ask Price
News -
Day High 0.61

Low
0.5162

52 Week Range

High
1.39

Day Low 0.57
Company Name Stock Ticker Symbol Market Type
AgeX Therapeutics Inc AGE AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02889 -4.81% 0.571408 13:24:48
Open Price Low Price High Price Close Price Prev Close
0.60 0.57 0.61 0.6003
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
77 23,817 $ 0.5858927 $ 13,954 - 0.5162 - 1.39
Last Trade Time Type Quantity Stock Price Currency
13:23:09 5,177 $ 0.571408 USD

Period:

Draw Mode:

AgeX Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 21.68M 37.95M 21.45M $ 40.00k $ - -0.24 -2.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.81M 0.30%

more financials information »

AgeX Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.590.640.570.606387313,872-0.01859-3.15%
1 Month0.62360.6880.550.632040221,110-0.05219-8.37%
3 Months0.560.690.53870.615550922,2170.011412.04%
6 Months0.75660.8130.53870.640314124,232-0.18519-24.48%
1 Year0.761.390.51620.9634754174,376-0.18859-24.81%
3 Years1.483.930.51622.11666,841-0.90859-61.39%
5 Years1.135.950.51622.17525,708-0.55859-49.43%

AgeX Therapeutics Description

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.